RAF1 and gastric cancer: In summary, TAF15 was found to be overexpressed in GC tumour tissues and cells and to contribute to GC malignant progression via the RAF1/MEK/ERK signalling pathway, which suggests that TAF15 might be a potential molecular diagnostic marker or therapeutic target for GC.